Northern Trust Corp Vor Biopharma Inc. Transaction History

Northern Trust Corp

$658 Billion
Q1 2025

A detailed history of Northern Trust Corp transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Northern Trust Corp holds 147,022 shares of VOR stock, worth $51,457. This represents 0.0% of its overall portfolio holdings.

Number of Shares

147,022

Previous 157,617 6.72%

Holding current value

$51,457

Previous $174,000 39.66%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$0.72 - $1.74 $7,628 - $18,435	-10,595 Reduced 6.72%	147,022 $105,000
Q4 2024 Feb 14, 2025	BUY	$0.64 - $1.27 $28,321 - $56,200	44,252 Added 39.03%	157,617 $174,000
Q3 2024 Nov 13, 2024	SELL	$0.7 - $1.1 $187,164 - $294,115	-267,378 Reduced 70.23%	113,365 $79,000
Q2 2024 Aug 14, 2024	SELL	$1.0 - $2.2 $17,619 - $38,761	-17,619 Reduced 4.42%	380,743 $380,000
Q1 2024 May 14, 2024	BUY	$1.8 - $2.85 $2,053 - $3,251	1,141 Added 0.29%	398,362 $944,000
Q4 2023 Feb 13, 2024	BUY	$1.66 - $2.63 $75,994 - $120,401	45,780 Added 13.03%	397,221 $893,000
Q3 2023 Nov 13, 2023	BUY	$2.1 - $3.35 $1,442 - $2,301	687 Added 0.2%	351,441 $745,000
Q2 2023 Aug 11, 2023	BUY	$3.09 - $5.33 $874,834 - $1.51 Million	283,118 Added 418.59%	350,754 $1.08 Million
Q1 2023 May 15, 2023	BUY	$4.68 - $6.96 $144,429 - $214,792	30,861 Added 83.92%	67,636 $363,000
Q4 2022 Feb 13, 2023	BUY	$3.77 - $7.43 $51,471 - $101,441	13,653 Added 59.05%	36,775 $244,000
Q3 2022 Nov 14, 2022	BUY	$3.9 - $5.52 $15,974 - $22,609	4,096 Added 21.53%	23,122 $92,000
Q2 2022 Aug 12, 2022	SELL	$3.89 - $6.44 $489,910 - $811,060	-125,941 Reduced 86.88%	19,026 $94,000
Q1 2022 May 13, 2022	SELL	$6.04 - $12.23 $42,032 - $85,108	-6,959 Reduced 4.58%	144,967 $875,000
Q4 2021 Feb 08, 2022	SELL	$11.32 - $18.02 $12,735 - $20,272	-1,125 Reduced 0.74%	151,926 $1.77 Million
Q3 2021 Nov 15, 2021	BUY	$12.24 - $20.38 $514,973 - $857,447	42,073 Added 37.91%	153,051 $2.4 Million
Q2 2021 Aug 13, 2021	SELL	$18.65 - $38.78 $204,702 - $425,649	-10,976 Reduced 9.0%	110,978 $2.07 Million
Q1 2021 May 12, 2021	BUY	$30.96 - $54.08 $3.78 Million - $6.6 Million	121,954 New	121,954 $5.26 Million

Others Institutions Holding VOR

# of Institutions

Shares Held

54.1M

Call Options Held

Put Options Held

View Full List

About Vor Biopharma Inc.

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $13.3M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

More about VOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Vor Biopharma Inc. Transaction History